LIVE WEBINAR
Wednesday, November 18th | 2pm ET
Duration: 1 hour
Can't make the live date? Register and we'll send you a link to the recording. ​

Employers have absorbed an untenably large share of healthcare inflation, and those pains aren’t likely to improve in the next year. Preparing for an 8.2% jump in health benefit expenses for 2027, many organizations are looking for ways to control costs without jeopardizing access for their workforce. They’re eyeing cancer benefits as a top priority—not to cut them, but to financially support more life-saving, cost-effective care. To be sure, cancer care has always been costly: Oncology treatments among working-age adults can average more than $300,000 per patient. But with innovations in advanced therapies like biologics, high-cost claims ($1M and above) are another emerging concern. With those pressures ongoing, 8 in 10 employers report cancer as their top healthcare cost driver. 

While options like stop-loss insurance help, organizations need a more systemic strategy that accounts for the actual drivers of high-cost cancer care. In this webinar, we’ll explore what those drivers are, according to actual claims data, as well as a proactive and modern approach to control for them by integrating pharmacy and medical benefits management. You’ll learn:

• The true cost drivers of cancer care, according to real claims data
• Strategies employers can use to manage high cancer care costs
• What integration between pharmacy and medical benefits looks like
• Future predictions for where cancer benefits go from here

SPEAKERS

Caroline Savello
President
Color Health
 

Josh Golden
​Senior Vice President of Strategy
Judi Rx